Experimental models for the study of drugs used to prevent and treat vascular diseases.
Paraskevas
Kosmas I
KI
Department of Clinical Biochemistry, (Vascular Disease Prevention Clinic), Royal Free Hospital and Royal Free University College Medical School, University College London, Pond Street, London NW3 2QG, UK.
Mikhailidis
Dimitri P
DP
Thompson
Cecil S
CS
D043925:Angiogenesis Inducing Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D000818:Animals; D000924:Anticholesteremic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D004195:Disease Models, Animal; D015195:Drug Design; D006801:Humans; D020138:Hyperhomocysteinemia / Q000188:drug therapy / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D007677:Kidney Function Tests; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000517:prevention & control; D012078:Renal Artery Obstruction / Q000188:drug therapy / Q000517:prevention & control; D014652:Vascular Diseases / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*
D043925:Angiogenesis Inducing Agents; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D000960:Hypolipidemic Agents